Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Scudder, C J; Kenny, P; Niessen, S J M
Languages: English
Types: Article
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Alenza DP, Arenas C, Lopez ML, Melian C (2006) Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism. J Am Anim Hosp Assoc 42: 269-76 Anderson CR, Birchard SJ, Powers BE, Belandria GA, Kuntz CA, Withrow SJ (2001) Surgical treatment of adrenocortical tumors: 21 cases (1990-1996). J Am Anim Hosp Assoc 37: 93-7 Andrade N, Rivas LR, Milovancev M, Radlinsky MA, Cornell K, Schmiedt C. (2014) Intercostal approach for right adrenalectomy in dogs. Vet Surg 43: 99-104
    • Arenas C, Melián C, Pérez-Alenza MD (2013) Evaluation of 2 trilostane protocols for the treatment of canine pituitary-dependent hyperadrenocorticism: Twice daily versus once daily. J Vet Intern Med 27: 1478-85
    • Arenas C, Melián C, Pérez-Alenza MD (2014) Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment. J Vet Intern Med 28: 473-80
    • Axlund TW, Behrend EN, Sorjonen DC, Simpson ST, Kemppainen RJ (2005) Ca- nine hypophysectomy using a ventral paramedian approach. Vet Surg 34: 179-89 Barker EN, Campbell S, Tebb AJ (2005) A comparison of the survival times of dogs treated with mitotane or trilostane for pituitary-dependent hyperadrenocorticism. J Vet Intern Med 19: 810-5 Barrera JS, Bernard F, Ehrhart EJ, Withrow SJ, Monnet E (2013) Evaluation of risk factors for outcome associated with adrenal gland tumors with or without invasion of the caudal vena cava and treated via adrenalectomy in dogs: 86 cases. J Am Vet Med Assoc 242: 1715-21 Rijnberk A, Belshaw B (1988) An alternative protocol for the medical management of canine pituitarydependent hyperadrenocorticism. Vet Rec 122: 486-8
    • Ritzel K, Beuschlein F, Mickisch A (2013) Clinical review: Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 98: 3939-48 Scavelli TD, Peterson ME, Matthiesen DT (1986) Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980-1984). J Am Vet Med Assoc 189: 1360-4
    • Schwartz P, Kovak JR, Koprowski A, Ludwig LL, Monette S, Bergman PJ (2008) Evaluation of prognostic factors in the surgical treatment of adrenal gland tumors in dogs: 41 cases (1999-2005). J Am Vet Med Assoc 232: 77-84 Schwedes CS (1997) Mitotane (o, p'-DDD) treatment in a cat with hyperadrenocorticism. J Small Anim Pract 38: 520-4
  • No related research data.
  • No similar publications.

Share - Bookmark

Download from

Cite this article